Andre Rogatko
|
Title(s) | Adjunct Professor, Medicine |
---|
School | Medicine |
---|
Address | 760 Westwood Plaza 32-144 Los Angeles CA 90024
|
---|
Phone | (310) 423-3316 |
---|
vCard | Download vCard |
---|
|
|
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Rationale and Design of the Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR) Trial. Am Heart J. 2021 Mar 18.
Handberg EM, Merz CNB, Cooper-Dehoff R, Wei J, Conlon M, Lo MC, Boden W, Frayne SM, Villines T, Spertus JA, Weintraub W, O'Malley P, Chaitman B, Shaw LJ, Budoff M, Rogatko A, Pepine CJ. PMID: 33745898.
View in: PubMed Mentions:
-
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD. J Clin Oncol. 2021 Jan 15; JCO2001086.
Watkins B, Qayed M, McCracken C, Bratrude B, Betz K, Suessmuth Y, Yu A, Sinclair S, Furlan S, Bosinger S, Tkachev V, Rhodes J, Tumlin AG, Narayan A, Cribbin K, Gillespie S, Gooley TA, Pasquini MC, Hebert K, Kapoor U, Rogatko A, Tighiouart M, Kim S, Bresee C, Choi SW, Davis J, Duncan C, Giller R, Grimley M, Harris AC, Jacobsohn D, Lalefar N, Norkin M, Farhadfar N, Pulsipher MA, Shenoy S, Petrovic A, Schultz KR, Yanik GA, Waller EK, Levine JE, Ferrara JL, Blazar BR, Langston A, Horan JT, Kean LS. PMID: 33449816.
View in: PubMed Mentions: Fields:
-
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. Clin Cancer Res. 2019 05 01; 25(9):2725-2736.
Crosby EJ, Gwin W, Blackwell K, Marcom PK, Chang S, Maecker HT, Broadwater G, Hyslop T, Kim S, Rogatko A, Lubkov V, Snyder JC, Osada T, Hobeika AC, Morse MA, Lyerly HK, Hartman ZC. PMID: 30635338.
-
Improving admission medication reconciliation with pharmacists or pharmacy technicians in the emergency department: a randomised controlled trial. BMJ Qual Saf. 2018 07; 27(7):512-520.
Pevnick JM, Nguyen C, Jackevicius CA, Palmer KA, Shane R, Cook-Wiens G, Rogatko A, Bear M, Rosen O, Seki D, Doyle B, Desai A, Bell DS. PMID: 28986515.
View in: PubMed Mentions: 7 Fields: Translation: Humans
-
Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: A multicenter study of 116 children with Hirschsprung disease. J Pediatr Surg. 2018 Apr; 53(4):708-717.
Frykman PK, Kim S, Wester T, Nordenskjöld A, Kawaguchi A, Hui TT, Teitelbaum DH, Granström AL, Rogatko A. PMID: 28760457.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
A Bayesian Adaptive Design for Combination of Three Drugs in Cancer Phase I Clinical Trials. Am J Biostat. 2016; 6(1):1-11.
Tighiouart M, Li Q, Piantadosi S, Rogatko A. PMID: 28706582.
View in: PubMed Mentions:
-
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clin Cancer Res. 2015 Apr 15; 21(8):1859-68.
Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu RW, Rossi MR, Auffermann WF, Torres WE, Bechara R, Deng X, Sun SY, Fu H, Gal AA, Khuri FR. PMID: 25673697.
View in: PubMed Mentions: 6 Fields: Translation: HumansCTClinical Trials
-
Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes. Am J Cardiol. 2015 Apr 15; 115(8):1073-9.
Zhang X, Li Q, Rogatko A, Tighiouart M, Hardison RM, Brooks MM, Kelsey SF, Kaul S, Bairey Merz CN. PMID: 25724784.
View in: PubMed Mentions: 1 Fields: Translation: Humans
-
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clin Cancer Res. 2014 Sep 01; 20(17):4636-46.
Josson S, Gururajan M, Hu P, Shao C, Chu GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, Lichterman J, Nandana S, Li Q, Rogatko A, Berel D, Posadas EM, Fazli L, Sareen D, Chung LW. PMID: 24963047.
View in: PubMed Mentions: 57 Fields: Translation: HumansAnimalsCells
-
Transferring inpatient rehabilitation facility cancer patients back to acute care (TRIPBAC). PM R. 2014 Sep; 6(9):808-13.
Asher A, Roberts PS, Bresee C, Zabel G, Riggs RV, Rogatko A. PMID: 24440553.
View in: PubMed Mentions: 4 Fields: Translation: Humans
-
Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. PLoS One. 2013; 8(9):e73081.
Hu P, Chung LW, Berel D, Frierson HF, Yang H, Liu C, Wang R, Li Q, Rogatko A, Zhau HE. PMID: 24066029.
View in: PubMed Mentions: 10 Fields: Translation: HumansCells
-
Inhibition of ß2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells. PLoS One. 2013; 8(7):e68366.
Josson S, Matsuoka Y, Gururajan M, Nomura T, Huang WC, Yang X, Lin JT, Bridgman R, Chu CY, Johnstone PA, Zayzafoon M, Hu P, Zhau H, Berel D, Rogatko A, Chung LW. PMID: 23874600.
View in: PubMed Mentions: 5 Fields: Translation: HumansAnimalsCells
-
Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation. J Pediatr Hematol Oncol. 2013 May; 35(4):e149-52.
Qayed M, Langston A, Chiang KY, August K, Hilinski JA, Cole CR, Rogatko A, Bostick RM, Horan JT. PMID: 23274384.
View in: PubMed Mentions: 2 Fields: Translation: HumansCellsCTClinical Trials
-
Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011 Feb; 35(2):161-76.
Nese N, Martignoni G, Fletcher CD, Gupta R, Pan CC, Kim H, Ro JY, Hwang IS, Sato K, Bonetti F, Pea M, Amin MB, Hes O, Svec A, Kida M, Vankalakunti M, Berel D, Rogatko A, Gown AM, Amin MB. PMID: 21263237.
View in: PubMed Mentions: 54 Fields: Translation: Humans
-
Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation? Pediatr Blood Cancer. 2010 Jul 15; 55(1):199-201.
Qayed M, Thompson A, Applegate K, Haight A, Rogatko A, Chiang KY, Horan J. PMID: 20486187.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2009 Sep 01; 27(25):4116-23.
Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB. PMID: 19636016.
View in: PubMed Mentions: 21 Fields: Translation: HumansCellsCTClinical Trials
-
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate. 2009 Jan 01; 69(1):1-11.
Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh CL, Lee JK, Xu Z, Rogatko A, Osunkoya AO, Zayzafoon M, Chung L, Petros JA. PMID: 18850577.
View in: PubMed Mentions: 27 Fields: Translation: HumansAnimalsCells
-
Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol. 2008 May 20; 26(15):2464-72.
Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, Rogatko A, Xu Z, Harris WB. PMID: 18487566.
View in: PubMed Mentions: 23 Fields: Translation: Humans
-
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma. Cancer. 2005 Aug 01; 104(3):561-9.
Kim ES, Kies MS, Fossella FV, Glisson BS, Zaknoen S, Statkevich P, Munden RF, Summey C, Pisters KM, Papadimitrakopoulou V, Tighiouart M, Rogatko A, Khuri FR. PMID: 16028213.
View in: PubMed Mentions: 20 Fields: Translation: HumansCTClinical Trials
-
Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer. 2005 Jul; 5(2):108-13.
Sundermeyer ML, Meropol NJ, Rogatko A, Wang H, Cohen SJ. PMID: 16098251.
View in: PubMed Mentions: 50 Fields: Translation: Humans
-
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res. 2005 Feb 01; 11(3):1226-36.
Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, Gold P, Rogatko A, Wang H, Blanchard RL. PMID: 15709193.
View in: PubMed Mentions: 53 Fields: Translation: HumansCTClinical Trials
-
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma. Haematologica. 2004 Dec; 89(12):1484-91.
Morris GJ, Millenson MM, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, Boyd RL, Yeslow G, Halbherr T, Schilder RJ, Smith MR. PMID: 15590399.
View in: PubMed Mentions: Fields: Translation: HumansCTClinical Trials
-
Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma. Cancer. 2004 Nov 01; 101(9):2034-41.
Borghaei H, Millenson M, Schilder R, Alden M, Rogatko A, Wang H, Padavic-Shaller K, Smith MR. PMID: 15455357.
View in: PubMed Mentions: Fields: Translation: HumansCTClinical Trials
-
Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line. Ann Surg Oncol. 2003 Oct; 10(8):910-5.
Brown T, Sigurdson E, Rogatko A, Broccoli D. PMID: 14527910.
View in: PubMed Mentions: 14 Fields: Translation: HumansCells
-
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res. 2003 Jan; 9(1):109-14.
Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. PMID: 12538458.
View in: PubMed Mentions: 5 Fields: Translation: HumansCTClinical Trials
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
2003 | 2 | 2004 | 2 | 2005 | 3 | 2008 | 1 | 2009 | 2 | 2010 | 1 | 2011 | 1 | 2013 | 3 | 2014 | 2 | 2015 | 2 | 2016 | 1 | 2017 | 2 | 2019 | 1 | 2021 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|